Revenues at constant exchange rates up 4.3% in the financial year 2018 to EUR 1,406.7m Adjusted EBITDA at constant exchange rates at EUR 307.5m, excluding the...
Duesseldorf, November 28, 2018 – Dr. Bernd Metzner (48) is to become Chief Financial Officer of Gerresheimer AG, taking up office at the latest on July 1,...
Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m Adjusted EBITDA at constant exchange rates—excluding Sensile Medical and...
Duesseldorf, October 11, 2018—Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in...
Düsseldorf/Paris, January 24, 2019. Gerresheimer will use this year's Pharmapack held in Paris, Porte de Versailles, as a platform to unveil their latest...
Düsseldorf/Paris, January 23, 2019. Gerresheimer will take the wraps off their first snap-on cap with child-resistant (CR) solution at booth B62 at this year's...
Gerresheimer is training its next generation of specialists at all production sites Düsseldorf, September 21, 2018. Seven of the Gerresheimer Group’s German...